Are liver enzymes elevated in Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) syndrome?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Are Liver Enzymes Elevated in DRESS Syndrome?

Yes, liver enzyme elevation is a hallmark feature of DRESS syndrome and represents one of the most common and clinically significant organ manifestations of this severe drug hypersensitivity reaction. 1, 2, 3

Hepatic Involvement as a Core Feature

Hepatitis with elevated transaminases (ALT, AST) is the primary organ manifestation in DRESS syndrome. 4 The liver is frequently involved, presenting as:

  • Elevated liver function tests (LFTs) including transaminases and cholestatic parameters that can increase dramatically during the course of the syndrome 5
  • ALT levels exceeding 2 times the upper limit of normal, which is part of the RegiSCAR diagnostic criteria for organ involvement 3
  • Immune-mediated hepatitis that can progress to severe acute hepatitis or even acute liver failure in some cases 1, 6

Clinical Patterns and Severity

The hepatic manifestations in DRESS syndrome follow specific patterns:

  • Liver enzyme elevations typically develop after the initial presentation, sometimes appearing normal at admission but then dramatically increasing during hospitalization 5
  • The severity ranges from mild transaminitis to fulminant liver failure, with the latter carrying significant mortality risk 6, 7
  • Mortality in DRESS syndrome (5-20%) is frequently attributed to hepatic complications, particularly fulminant liver failure 5, 7

Diagnostic Workup

A comprehensive metabolic panel evaluating liver function (ALT, AST, alkaline phosphatase, bilirubin) is crucial in diagnosing DRESS syndrome. 3 The workup should include:

  • Complete blood count with differential to assess for eosinophilia (>700/μL or >10%) 3
  • Serial monitoring of liver enzymes as they may worsen despite initial treatment 5, 7
  • Kidney function tests (BUN, creatinine) as renal involvement can coexist 3, 4

Treatment Response

After appropriate treatment with systemic corticosteroids and/or IVIG, liver enzymes typically improve substantially within a median time of 13 days (range 0-27 days). 8 However:

  • Immediate withdrawal of the causative drug is the most crucial first step, as continued exposure worsens hepatic injury 2, 6
  • Systemic corticosteroids are the mainstay of treatment for DRESS syndrome with hepatic involvement, unlike in Stevens-Johnson syndrome where they may be contraindicated 2
  • IVIG at 1-2 g/kg total dosage should be considered in patients not responding to systemic steroids 2, 8

Common Pitfalls

Do not dismiss normal initial liver enzymes as ruling out DRESS syndrome—they can be normal at presentation and then dramatically increase during the disease course. 5 Additionally:

  • The latency period of 2-6 weeks (typically 6 weeks) after drug initiation helps distinguish DRESS from other drug reactions 2, 3
  • Eosinophilia may develop after liver enzyme elevation, so timing of laboratory abnormalities varies 5
  • Prolonged steroid taper over at least 4 weeks is necessary to prevent relapse, as DRESS involves T-cell immune-directed toxicity 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment of DRESS Syndrome

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

DRESS Syndrome Diagnostic Criteria and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Acute Hepatitis in the DRESS Syndrome.

GE Portuguese journal of gastroenterology, 2016

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.